ARCALYST Trademark

Trademark Overview

On Friday, December 16, 2011, a trademark application was filed for ARCALYST with the United States Patent and Trademark Office. The USPTO has given the ARCALYST trademark a serial number of 85497724. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 24, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The ARCALYST trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceutical preparations and substances for the treatment of inflammatory diseases and disorders
arcalyst

General Information

Serial Number85497724
Word MarkARCALYST
Filing DateFriday, December 16, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 24, 2023
Registration Number4189984
Registration DateTuesday, August 14, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 29, 2012

Trademark Statements

Description of MarkThe mark consists of the word "ARCALYST" with a spiral design to the left of the word "ARCALYST".
Goods and ServicesInjectable pharmaceutical preparations and substances for the treatment of inflammatory diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 24, 2023
Primary Code005
First Use Anywhere DateFriday, February 29, 2008
First Use In Commerce DateFriday, February 29, 2008

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, February 24, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, August 14, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, June 14, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 14, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 14, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 4, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, August 14, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 6, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 6, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 14, 2012REGISTERED-PRINCIPAL REGISTER
Tuesday, May 29, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 29, 2012PUBLISHED FOR OPPOSITION
Wednesday, May 9, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 23, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 18, 2012ASSIGNED TO LIE
Wednesday, March 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 27, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 27, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 27, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 24, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 24, 2012NON-FINAL ACTION E-MAILED
Saturday, March 24, 2012NON-FINAL ACTION WRITTEN
Saturday, March 24, 2012ASSIGNED TO EXAMINER
Thursday, December 29, 2011NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, December 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 20, 2011NEW APPLICATION ENTERED

Related Keywords

arcalyst inflammatory diseases disorders treatment substances pharmaceutical preparations injectable